*** Disclaimer: This Database is still undergoing update on daily basis to prevent errors, discrepancies, and missing records. Please Contact FDIC@nafdac.gov.ng for enquires ***

Product Details

Ocrevus

Ocrelizumab
300mg/vial
Intravenous infusion

ROA

Intravenous

Applicant Name

Roche Products Limited

NRN

A6-100051

Status

Active


ATC Code

L04AA36  

Product Category

Vaccines and Biologics

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1*10ml  

Product Description

Ocrevus Ocrelizumab Ocrelizumab 300mg/vial... Sodium Acetate Trihydrate, 21.4mg/vial......Glacial Actetic Acid, 2.5mg//vial.......... a , a - Trehalose dihydrate polysorbate ,400.0mg/via....polysorbate20, 2.0mg/vial... Water for Injection, QS 10.0ml/vial Vaccines & Biologicals Biologics Imported Products 1*10ml 07/10/2020 Roche Products Limited, 8th Floor, Roche Office 21 Mobolaji Bank Anthony Way, Etiebet's Place, Ikeja. Lagos 8056292219 angela.essien@roche.com Roche Diagnostics GmbH, Mannheim Sandhofer Strasse 116 D-68305 Mannheim, Germany, Roche Diagnostics GmbH, Mannheim Sandhofer Strasse 116 D-68305 Mannheim, Germany, Germany

Manufacturer Name

Roche Diagnostics Gmbh Mannheim, Germany

Manufacturer Country

GERMANY  

Approval Date

2022-05-24  

Expiry Date

2027-05-23